© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Scopolamine butylbromide doesn’t get a lot of headlines in the mainstream media, but its journey weaves through the tale of modern medicine’s push to make life a little smoother for those wrangling with painful cramps and spasms. Looking back, the roots of scopolamine—the parent compound—emerged from the curious minds who investigated plants like Duboisia and Hyoscyamus niger. In the early 1900s, chemists zeroed in on these alkaloids, hoping to split out the toxic from the therapeutic. Scopolamine butylbromide, a quaternary ammonium derivative, arrived on the scene a bit later. The intent was direct: tweak the chemistry to keep its antispasmodic benefits while blocking its sedative and central nervous effects. In the heyday of chemical pharmacology—1930s through the 1950s—this led to safer, more targeted options in the pharmacy. Scopolamine butylbromide earned wide acceptance as doctors reached for it in cases of stomach pain, cramps, and irritable bowel complaints that traditional remedies failed to soothe.
Pharmacy shelves label this compound in a few different ways—Buscopan being the flagship brand, but synonyms stack up: Hyoscine butylbromide, Scopolamine methylbromide, and a variety of local names in global markets. It usually comes as tablets or injectables, meant for oral or parenteral administration depending on how badly someone needs relief. Doctors and patients alike appreciate its focused job—dialing down gastrointestinal and genitourinary spasms without sedating the person or messing with their mental sharpness.
Scopolamine butylbromide shows up as a white, odorless, crystalline powder. Its quaternary ammonium ion structure hinders it from crossing the blood-brain barrier, which on the ground means fewer central nervous side effects compared with regular scopolamine. The molecular formula, C21H30BrNO4, gives it heft and resilience but also makes it sparingly soluble in water and almost insoluble in organic solvents. What I find handy about this property—especially for those involved in prep and storage—is that it helps maintain stability in real-world conditions. There’s no odd melting or unexpected breakdown under regular pharmacy storage.
Doctors expect consistency. Scopolamine butylbromide comes with tightly controlled purity standards, usually above 99 percent for pharmaceutical grades. Labels require the clear statement of active ingredient, exact weight per tablet or volume per ampoule, and an exhaustive list of excipients. In my experience, especially in regulated markets like the EU and US, these details make or break a batch. Pharmacies want to see expiry dates, lot numbers, and a clear route of administration. Any deviation quickly lands the batch in quarantine—or worse, triggers a recall.
Preparing scopolamine butylbromide is no walk in the park. It starts by extracting scopolamine from plant sources using acidified solvents, then moving through a synthesis step that swaps a bromide for increased water solubility and quaternary structure. This chemical modification, in the hands of an experienced organic chemist, is what turns a psychoactive plant alkaloid into a gut-friendly remedy. Labs sometimes tweak the method to strip unwanted by-products or boost yield, but the road map—extraction, purification, quaternization—remains steady.
The transformation from regular scopolamine to the butylbromide salt involves a quaternization reaction, so a tertiary amine picks up an alkyl group and becomes a quaternary ammonium compound. This simple-sounding chemistry blocks the molecule from getting into the brain, which translates to a medication that calms spasms in the gut without fogging up the mind. While generic manufacturers occasionally shift minor ingredients for cost or regulatory reasons, the backbone stays the same. There’s also limited room for novel analogs—regulators and clinicians know what works, and the market has little patience for surprise side effects.
In any pharmacy, the conversation about scopolamine butylbromide moves quickly to safety. This compound avoids the dangerous territory of CNS effects that many classical antimuscarinics encounter. Doses for adults seldom cause trouble beyond mild dry mouth or a tickle of constipation. For hospitals and clinics, it helps that the injection route gives tight control—if someone gets too much, typical side effects fade fast after stopping. Medical training drills home the need to watch for rare cases of urinary retention or increased heart rate, especially in the elderly. Still, mishaps remain rare under proper supervision.
Scopolamine butylbromide’s bread and butter lies in cases of stomach cramps, irritable bowel agitation, and spasms that resist other over-the-counter remedies. Emergency rooms often deliver it via injection to ease severe visceral pain from kidney stones or gallbladder trouble. Outpatient doctors script the tablets for chronic abdominal discomfort and functional bowel disorders. I’ve seen anxious parents sigh with relief after a dose stops a child’s colicky agony. Gynecologists and radiologists also tap into its powers by using injections to smooth muscle before certain exams or procedures. Its reach spans general practitioners, specialists, and acute care facilities—proof that a well-crafted, reliable solution finds a foothold in nearly every healthcare system.
Ongoing studies continue to probe scopolamine butylbromide’s potential in areas like palliative care, premedication before surgery, and functional urological disorders. Investigators check if combinations with other antispasmodics or analgesics ramp up its benefits, or if alternative dosing schedules work better for chronic sufferers. Trials also challenge the status quo on safety in special populations, such as pregnant women and children. Universities and pharmaceutical firms sift through the molecular tweaks, hoping for a better side effect profile or expanded claims for gastrointestinal disorders. The steady flow of journal articles and clinical trials signals that the field refuses to settle or coast on past success, a trait that keeps medicine moving forward.
Every anticholinergic drug, including scopolamine butylbromide, draws a line between relief and risk. Preclinical and clinical studies show that toxicity remains moderate, especially compared to other antimuscarinics. Its inability to cross the blood-brain barrier shields patients from delirium or memory trouble, but massive overdoses can still push heart rate, trigger dangerous dry mouth, paralyze the gut, or worsen angle-closure glaucoma. Poison control centers keep protocols handy, and frontline staff monitor high-risk patients, especially with injections or in children. Broad experience and a strong safety record don’t eliminate risk, but they shrink it to a manageable scale in real-world practice.
Many medications rise, shine, and then get replaced by something with flashier marketing or a marginal improvement. Scopolamine butylbromide holds steady. Doctors trust it. Patients keep asking for it. Trends in gastrointestinal and pain research hunt for less-invasive alternatives, but achieving targeted relief with minimal central effects still counts for a lot in clinical decisions. Some research teams test slow-release formulations and look into new administration routes that could open up fresh uses. Its role in surgical and diagnostic settings may grow further as minimally invasive medicine expands. Long-term, environmental concerns about pharmaceutical manufacturing and waste could nudge labs to streamline extraction and synthesis, but the basic chemistry likely remains. As long as patients grapple with abdominal pain, there’s a case for keeping this tried-and-true molecule in the toolkit.
Scopolamine butylbromide has landed a spot in many household medicine cabinets, especially for those who have faced the sharp, distractingly painful cramps of stomach or gut conditions. Sold under names like Buscopan, it has earned the trust of doctors for decades by helping people find quick relief from muscle spasms in the belly and gut. Growing up with family members who relied on it for chronic abdominal pain, I know firsthand that the relief is more than just medical—it brings the comfort needed to get through a rough day.
Many who struggle with irritable bowel syndrome (IBS), minor bladder spasms, or even pain linked to periods, have likely encountered scopolamine butylbromide in a prescription. The real problem here is muscle spasms. Imagine sitting at work, trying to focus, but that familiar twisting pain keeps surfacing. Scopolamine butylbromide targets those cramping muscles. It blocks certain nerve signals, which calms the contractions and relaxes the gut. With over 10% of people worldwide dealing with IBS alone, the value of an accessible, fast-acting spasm reliever can’t be brushed aside.
No one wants to feel foggy or dizzy just because their gut decided to storm. One of the key features of scopolamine butylbromide is that it doesn’t cross the blood-brain barrier easily. This means fewer side effects for most people—a major advantage compared to some older, broad-spectrum muscle relaxants that sparked drowsiness or confusion. In practice, it's especially useful during travel or stressful situations, which can trigger sudden cramps for many with nervous guts. Overuse, though, can lead to dry mouth or blurred vision. It’s not a 'take it and forget it' pill, and ignoring medical advice can bring trouble. Doctors usually check for any underlying conditions, since masking symptoms can delay a serious diagnosis.
The World Health Organization lists scopolamine butylbromide as an essential medicine, and it sees regular use in clinics and emergency rooms. Quality research, including randomized controlled trials, has shown its benefit not just for chronic problems, but also for acute pain—think sudden kidney stones or gallbladder attacks. Europe and Asia have depended on this medicine for years. In some regions, doctors mix it with painkillers to help manage pain after surgery or procedures like endoscopy, so patients recover in less distress.
One of the main challenges lies in making sure that people understand the proper use. In communities where self-medication is common, there’s a risk that folks will reach for pills to numb pain instead of investigating what’s really sparking that pain. Public health campaigns could help. Sharing accurate information about the situations where scopolamine butylbromide is helpful—like IBS, painful periods, or travel-related cramps—could cut down on misuse.
Education isn't just for patients. Pharmacists and clinic staff play a big role in asking the right questions, spotting red flags, and guiding folks toward professional help if cramps might be hiding something more serious. The ability to ease pain without fogging the mind changes lives, but guidance from well-trained professionals ensures relief stays safe and effective.
If you’ve taken Scopolamine Butylbromide for cramps or those stubborn gut spasms, you probably already know this medicine helps slow things down in the digestive tract. The tricky part: it often brings a few annoying side effects along for the ride. Dry mouth stands out as the one that most folks notice first—cotton-mouth kicks in not long after the tablets go down. Talking leaves your mouth sticky and swallowing feels odd. I remember sitting at work, sipping water every few minutes because my tongue felt like sandpaper.
Next up, constipation tends to follow closely. The medicine works by relaxing your gut muscles, but it can go too far. Stools turn hard, and bathroom trips grow less regular. Plenty of patients gripe about bloating—your belly feels full, sometimes tight, and pants fit a little bit differently after a few days on this drug.
Vision changes cause a fair bit of surprise. Blurry eyesight or trouble focusing, especially trying to read small print, has left many coworkers squinting at screens or holding their phones at odd angles. I’ve had my share of headaches from just trying to tough it out.
Scopolamine butylbromide blocks the action of a body chemical called acetylcholine. This chemical keeps saliva flowing, helps digest food, and makes the gut work like a well-oiled machine. Once you stop acetylcholine in its tracks, you get a desert-dry mouth, sluggish bowels, and less sweat. It hits your eyes, too—some folks report their pupils get bigger, which makes it tough to handle sunlight without sunglasses.
Less sweat may sound harmless, but working outdoors or in heat gets dangerous, fast. Your body can’t cool off properly. Feeling a bit hotter than everyone else during summer errands or yardwork becomes more than just an inconvenience.
Most symptoms sit on the mild side. A dry tongue, a little constipation, and wonky eyesight don’t scream medical emergency, though they’re hard to ignore. A couple of glasses of water often brings relief. Patients who eat more fiber and get up for short walks deal better with sluggish guts. Picking sunglasses with good coverage keeps headaches from bright lights to a minimum.
A handful of people run into bigger trouble. I’ve met folks who react with an allergic rash or hives—itching, swelling, and trouble breathing pop up quickly. Racing heartbeat, confusion, or trouble passing urine point to serious problems. These side effects need immediate medical attention. Doctors usually discuss warning signs with patients new to this medicine. If you notice anything feels way off, don’t wait it out.
To dodge the worst of these symptoms, staying hydrated works for most people. Sipping cold water, chewing gum, or sucking on sugarless candies can help soothe a parched throat. Swapping greasy, heavy meals for lighter fare with veggies tackles constipation. Taking the pills after a quick bite helps settle your stomach.
It helps to talk openly with your family doctor or pharmacist about other drugs and supplements. Mixing medications ramps up the risk of more side effects. Regular medication reviews mean less guesswork and more tailored care.
Scopolamine butylbromide rarely causes anything life-threatening if taken as prescribed. Still, every medicine comes with trade-offs. What brings relief for one person could be misery for another. Everyone has a story—and it’s always worth sharing your experiences with those making your health decisions.
Most folks take Scopolamine Butylbromide to relieve stomach cramps, gut spasms, or pain caused by conditions such as irritable bowel syndrome. Others get it for bladder spasms. The way this medicine eases smooth muscle tension can make a real difference to daily comfort, especially during flare-ups.
Doctors usually recommend a dose based on age and the severity of symptoms. For most adults, one 10 mg tablet a few times a day is common. Children typically need a lower dose, so sticking to a doctor’s advice is important. Some people end up with a higher frequency during bad spells, yet taking more doesn’t equal better relief. Too much can trigger side effects, like dry mouth or blurred vision. Having seen friends rush for pain relief, I've learned that taking more medicine than prescribed just brings a new set of problems without solving the old ones.
Most people swallow Scopolamine Butylbromide tablets whole, with water. Crushing or chewing the tablet can mess with how the medicine moves through the body. For folks who can’t take tablets, doctors sometimes provide it as a solution or an injection. Hospitals often use the injectable form when someone needs quick action, especially if vomiting or severe pain prevents taking a pill. Health professionals make these decisions based on the fastest, safest route for each patient.
Some medicines work better with food in the stomach, but Scopolamine Butylbromide isn’t too picky about meals. Taking it before or after eating—either way, it calms those twisting muscles. Even so, drinking a full glass of water seems to make swallowing easier and helps avoid possible irritation. My own experience during exam stress reminded me that skipping meals does nothing for gut cramps; instead, sipping enough water and having light food made the medicine work smoother.
Like a lot of drugs, it has some unwanted effects. Dry mouth, rapid heart rate, or blurry eyesight pop up in some people. Sometimes, the medicine lowers the ability to sweat, so staying cool in hot weather matters. If dizziness or an erratic heartbeat shows up, it's a good idea to inform a doctor rather than push through or double-check advice online. I’ve had relatives ignore side effects thinking they’ll pass, only to end up back in the clinic, regretting the delay. Honest reporting to healthcare providers shortens the problem and helps avoid complications.
Some folks with glaucoma, enlarged prostate, or specific heart conditions should steer clear of Scopolamine Butylbromide or use it only under strict supervision. The drug can mix badly with certain antidepressants, antihistamines, or medicines for Parkinson’s disease. Keeping a current medication list is crucial, especially with multiple prescriptions. Doctors can watch out for bad combinations, but only if they know what’s really being taken.
Most pharmacists suggest keeping the medicine in its original packaging, out of reach of children. Following the schedule on the label prevents double doses. Anytime a dose gets missed, it helps to ask a pharmacist rather than guess. If symptoms do not improve or get worse, a follow-up with the prescriber could uncover a better strategy or spot other health issues early.
Taking Scopolamine Butylbromide works best with a doctor’s guidance, respect for the dose, and listening to the body’s response. Open talks with healthcare providers, a little care with timing, and honest communication about other health problems turn this medicine into a helpful partner rather than an unpredictable intruder.
Folks hear the name Scopolamine Butylbromide and some think of quick relief for stomach cramps or irritable bowel discomfort. It’s easy to see the appeal—relieve a spasm, get on with the day. For many, it’s as simple as swallowing a pill or taking a shot at the doctor’s office. I’ve seen the comfort it brings to friends battling gut pain. Still, a closer look shows it’s not for everybody, and ignoring the warnings can stir up serious trouble.
Allergies aren’t just annoying. They can end up deadly. Scopolamine Butylbromide spells real risk for those who know their body reacts poorly to belladonna alkaloids or have had reactions to similar medicines before. The itching, rash, or swelling is one thing. A full-body reaction that closes airways is another. Folks with any record of reactions should talk it over with their healthcare provider. Guesswork here is a bad move.
Scopolamine Butylbromide tightens the drain in the eyes. For those with narrow-angle glaucoma, that’s like pouring water into a sink with a stopped-up drain. Pressure builds fast, and sudden pain or vision loss can happen. Spotting these issues late lands people in the emergency room.
Older men often deal with trouble in the bathroom, and a swollen prostate just makes life harder. Scopolamine Butylbromide relaxes muscles that control organs like the bladder. In some cases, urine just won’t come out. For men who already dread the bathroom door, this medicine adds another layer of stress.
Heart troubles make life unpredictable. Scopolamine Butylbromide speeds up the heart and flips the balance on circulation. Folks with rapid heartbeats, heart attacks, or blocked arteries stand to lose more than they gain. I’ve read stories of people with weak hearts getting dizzy or faint from a simple pill. Heart medication and Scopolamine can clash, making symptoms much worse.
Stomach pain comes with a long list of causes. A simple belly cramp feels a lot different from a twisted gut or a blockage. If the intestine is blocked, doctors need to see everything clearly— not masked by a medicine that quiets pain. Scopolamine Butylbromide can cloud the symptoms, so someone with real trouble might wait too long before getting help.
Children and older adults feel medicine’s side effects more. Confusion, dry mouth, or trouble passing urine pop up faster in these groups. Pregnant and breastfeeding women also steer clear unless a trusted medical expert gives it the green light. The baby’s health should come first, every time.
No medicine comes with a blanket promise for everyone. Clear advice from health workers, honest talks about past health problems, and careful reading of the leaflet inside the pack—all help steer people clear of danger. It’s about making space for safer choices and protecting those who might get hurt the most.
Scopolamine butylbromide, known by names like Buscopan, shows up on many medicine shelves for good reason. Doctors often hand it out to help with stomach cramps or certain abdominal pains, and some folks see real relief from it. Once pregnancy and breastfeeding come into the picture, the story gets complicated fast, because a mother’s decisions affect more than just herself.
Pregnancy throws a lot of curveballs. Each pill has to be measured not just for how it helps, but what unseen risks it might bring along. Scopolamine butylbromide hasn’t received the green light for pregnant women without a lot of hesitation. Medical guidelines pull from studies in animals or small samples, which don’t always match up with real-life pregnancy experiences in humans. The U.S. Food and Drug Administration (FDA) grouped scopolamine butylbromide in Category B in the past, because animal studies didn’t flag clear dangers to unborn babies—but they also point out there’s not enough data from people to say it’s risk-free.
Pregnancy already comes with enough questions, and medical science still can’t promise total safety for this drug in that setting. Any possible benefit from scopolamine butylbromide during pregnancy really needs to make sense in light of what could go wrong. OB-GYN groups suggest looking for alternative options, especially for manageable symptoms.
Once the baby arrives, the equation changes again. Newborns are sensitive, and mothers wonder what might sneak through in their breast milk. Scopolamine butylbromide rates as a quaternary ammonium compound—it’s not supposed to cross over into breast milk easily, but research comes up short here. Without clear answers, most doctors urge caution. Plenty of cases show newborns handling small exposures to many drugs just fine, but no mother wants to wager on those odds. I’ve seen new moms and their doctors choose pain relief approaches tested as safer while breastfeeding. There’s relief in sticking to medications with longer track records for nursing safety.
People can’t always avoid medications during pregnancy or while nursing, but it’s important to lean on reliable sources and doctors instead of online forums packed with half-true stories. The gut instinct for caution makes sense here. Organizations like the World Health Organization and the American College of Obstetricians and Gynecologists both push for careful weighing of risks and benefits for each situation.
It helps to keep these questions front and center at every doctor visit: Is there a safer alternative? Will dosage and timing matter? Even small changes can help steer toward the best outcome for both the parent and the baby. Honest talks lay the groundwork for making tricky decisions a little less lonely and a lot safer.
Science keeps moving forward, but until better studies arrive, the safest route for mothers-to-be or breastfeeding women usually starts with tried-and-tested treatments, not guesswork. Pharmacists and healthcare providers carry experience and up-to-date research, and they know the latest recommendations. This is no time to treat recommendations as just paperwork — real risks sometimes hide in the details, especially in such an important chapter of life. For families, pressing for more research and open conversations with medical professionals matters more than memorizing drug labels. Staying clear-eyed about what’s known, what’s uncertain, and who can help forms the strongest shield for both the patient and her baby.
| Names | |
| Preferred IUPAC name | N-butyl-3-hydroxy-2-phenyl-1-azabicyclo[3.2.1]octan-8-yl bromide-6,7-epoxy tropan-3-yl ester |
| Other names |
Hyoscine Butylbromide Butylscopolamine Buscopan |
| Pronunciation | /skəˈpɒl.ə.miːn ˌbjuː.tɪlˈbroʊ.maɪd/ |
| Identifiers | |
| CAS Number | 149-64-4 |
| 3D model (JSmol) | `3D model (JSmol)` string for Scopolamine Butylbromide (Hyoscine butylbromide): ``` CN1[C@@H]2CC[C@H]1C[C@H](O2)C(=O)OC(C)(C)CCC[N+](C)(C)C.[Br-] ``` |
| Beilstein Reference | 96963 |
| ChEBI | CHEBI:9070 |
| ChEMBL | CHEMBL649 |
| ChemSpider | 2157 |
| DrugBank | DB00404 |
| ECHA InfoCard | 03b471ec-3f1a-44e5-aa2c-2daf7fd4b7b7 |
| EC Number | 208-953-6 |
| Gmelin Reference | 41992 |
| KEGG | D08415 |
| MeSH | D013361 |
| PubChem CID | 656606 |
| RTECS number | GN7445000 |
| UNII | N7U69T8B9B |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DTXSID9070253 |
| Properties | |
| Chemical formula | C21H30BrNO4 |
| Molar mass | 440.4 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.23 g/cm³ |
| Solubility in water | Very slightly soluble in water |
| log P | -3.8 |
| Acidity (pKa) | 13.35 |
| Basicity (pKb) | 4.32 |
| Magnetic susceptibility (χ) | -75.0×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.64 |
| Viscosity | Viscosity: 1.068 mPa.s (20°C) |
| Dipole moment | 4.49 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 536.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | A03BA03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| Autoignition temperature | > 400 °C |
| Lethal dose or concentration | LD50 (rat, oral): 1040 mg/kg |
| LD50 (median dose) | LD50 (median dose): 1040 mg/kg (rat, oral) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1 mg/m³ |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Atropine Hyoscine Scopolamine Ipratropium bromide Tiotropium bromide |
